发布求助
文献互助 智能选刊 最新文献

Section 3: Production and Compounding最新文献

筛选
英文 中文
3PC-029 Management of a chemotherapy production after a cyber-attack in a public hospital 公立医院遭受网络攻击后化疗产品的管理
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.46
S. Muhammad, E. Gaspéri, F. Bordet, ML Maëstroni
{"title":"3PC-029 Management of a chemotherapy production after a cyber-attack in a public hospital","authors":"S. Muhammad, E. Gaspéri, F. Bordet, ML Maëstroni","doi":"10.1136/ejhpharm-2023-eahp.46","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.46","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"108 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125184431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-017 Impact of agitation on pembrolizumab (Keytruda®) safety and efficacy: aggregation and functionality 躁动对pembrolizumab (Keytruda®)安全性和有效性的影响:聚集性和功能性
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.40
A. Torrente-López, R. Pérez-Robles, J. Hermosilla, J. Ruiz-Travé, M. Hernández-García, A. Torres, J. Cabeza, A. Salmerón-García, N. Navas
{"title":"3PC-017 Impact of agitation on pembrolizumab (Keytruda®) safety and efficacy: aggregation and functionality","authors":"A. Torrente-López, R. Pérez-Robles, J. Hermosilla, J. Ruiz-Travé, M. Hernández-García, A. Torres, J. Cabeza, A. Salmerón-García, N. Navas","doi":"10.1136/ejhpharm-2023-eahp.40","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.40","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116714092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-009 Cyclophosphamide surface contamination in a robotic chemotherapy compounding process 机器人化疗复合过程中的环磷酰胺表面污染
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.34
AC Riestra Ayora, M. Tamés, A. Iglesias, B. García, MJ Argandoña, C. Ramajo, O. Olariaga, M. Urretavizcaya
{"title":"3PC-009 Cyclophosphamide surface contamination in a robotic chemotherapy compounding process","authors":"AC Riestra Ayora, M. Tamés, A. Iglesias, B. García, MJ Argandoña, C. Ramajo, O. Olariaga, M. Urretavizcaya","doi":"10.1136/ejhpharm-2023-eahp.34","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.34","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"286 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122383663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-010 Formulation of tacrolimus solution for sublingual use 舌下使用他克莫司溶液的配方
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.35
E. Kasalová, S. Klovrzova, R. Kadlecová, M. Hojný
{"title":"3PC-010 Formulation of tacrolimus solution for sublingual use","authors":"E. Kasalová, S. Klovrzova, R. Kadlecová, M. Hojný","doi":"10.1136/ejhpharm-2023-eahp.35","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.35","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"433 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115933896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-005 Closed system transfer device (CSTD) extends practical in-use shelf life to 28 days after first puncture of non-preserved single-use-vials in both controlled and uncontrolled environments 封闭系统传输装置(CSTD)在受控和非受控环境中首次穿刺非保存的一次性小瓶后，将实际使用中的保质期延长至28天
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.31
R. Terkola, C. Pietrzak, AS Nebel
{"title":"3PC-005 Closed system transfer device (CSTD) extends practical in-use shelf life to 28 days after first puncture of non-preserved single-use-vials in both controlled and uncontrolled environments","authors":"R. Terkola, C. Pietrzak, AS Nebel","doi":"10.1136/ejhpharm-2023-eahp.31","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.31","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115715749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-011 A virtual sterilisation area: an interactive training tool 虚拟灭菌区:交互式培训工具
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.36
A. Crou, D. Boden, P. Perot, G. Desautez, V. Chevalet, R. Schofield, A. Ghazouani
{"title":"3PC-011 A virtual sterilisation area: an interactive training tool","authors":"A. Crou, D. Boden, P. Perot, G. Desautez, V. Chevalet, R. Schofield, A. Ghazouani","doi":"10.1136/ejhpharm-2023-eahp.36","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.36","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"97 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123046345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-026 Effectiveness and safety of insulin 1UI/mL eye drops 胰岛素1UI/mL滴眼液的有效性和安全性
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.44
C. Apezteguia Fernández, MP Bautista Sanz, A. Melgarejo Ortuño, E. Matilla García, B. Rodríguez Vargas, C. de Cáceres Velasco, MÁ Amor García, R. Moreno Diaz
{"title":"3PC-026 Effectiveness and safety of insulin 1UI/mL eye drops","authors":"C. Apezteguia Fernández, MP Bautista Sanz, A. Melgarejo Ortuño, E. Matilla García, B. Rodríguez Vargas, C. de Cáceres Velasco, MÁ Amor García, R. Moreno Diaz","doi":"10.1136/ejhpharm-2023-eahp.44","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.44","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"217 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122053064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-037 Liquid chromatography mass spectrometry analysis of doxorubicin and epirubicin after freezing 3PC-037冷冻后阿霉素和表阿霉素的液相色谱质谱分析
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.50
V. Garau, M. Crobeddu, GA Carrucciu, P. Serra, P. Caboni
{"title":"3PC-037 Liquid chromatography mass spectrometry analysis of doxorubicin and epirubicin after freezing","authors":"V. Garau, M. Crobeddu, GA Carrucciu, P. Serra, P. Caboni","doi":"10.1136/ejhpharm-2023-eahp.50","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.50","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"148 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116560260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-004 Economic savings of erenumab redosing in a third-level hospital 三级医院伊莫那布再给药的经济节约
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.30
R. López Ranchal, CC Cabañas Gimeno, N. Báez, LM Ruiz Lara, E. Mancilla Montero
{"title":"3PC-004 Economic savings of erenumab redosing in a third-level hospital","authors":"R. López Ranchal, CC Cabañas Gimeno, N. Báez, LM Ruiz Lara, E. Mancilla Montero","doi":"10.1136/ejhpharm-2023-eahp.30","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.30","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121289754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3PC-023 Patch tests with ethambutol 10%, isoniazid 15% and pyrazinamide 25%: a case report 用乙胺丁醇10%、异烟肼15%、吡嗪酰胺25%进行斑贴试验:1例报告
Section 3: Production and Compounding Pub Date : 2023-03-01 DOI: 10.1136/ejhpharm-2023-eahp.43
C. Leitão, R. Araújo, C. Ferreira, M. Vieira
{"title":"3PC-023 Patch tests with ethambutol 10%, isoniazid 15% and pyrazinamide 25%: a case report","authors":"C. Leitão, R. Araújo, C. Ferreira, M. Vieira","doi":"10.1136/ejhpharm-2023-eahp.43","DOIUrl":"https://doi.org/10.1136/ejhpharm-2023-eahp.43","url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127931637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信